Role of aspirin desensitization in the management of chronic rhinosinusitis

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 19, Issue 3, 2011, Pages 210-217

  Rizk, Habib ^a  

^a SAINT JOSEPH UNIVERSITY   (Lebanon)

Author keywords

aspirin desensitization; aspirin exacerbated respiratory disease; chronic rhinosinusitis with nasal polyposis; cysteinyl leukotrienes

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; ANTIHISTAMINIC AGENT; ARACHIDONIC ACID; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CELECOXIB; CORTICOSTEROID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 3; DECONGESTIVE AGENT; DIPHENHYDRAMINE; INTERLEUKIN 13; INTERLEUKIN 4; LYSINE ACETYLSALICYLATE; MONTELUKAST; PARACETAMOL; PEPTIDOLEUKOTRIENE; RANITIDINE;

ABDOMINAL CRAMP; ANGIONEUROTIC EDEMA; ASPIRIN EXACERBATED RESPIRATORY DISEASE; BRONCHOSPASM; BRONCHUS DISEASE; CHRONIC DISEASE; CHRONIC SINUSITIS WITH NASAL POLYPOSIS; CLINICAL ASSESSMENT; CLINICAL FEATURE; DESENSITIZATION; DIAGNOSTIC VALUE; DISEASE EXACERBATION; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EYE DISEASE; FORCED EXPIRATORY VOLUME; HUMAN; HYPOTENSION; INDUCED HYPOTENSION; LARYNX DISORDER; LOW DRUG DOSE; NOSE DISEASE; NOSE POLYP; OUTCOME ASSESSMENT; PARACETAMOL INDUCED BRONCHOSPASTIC REACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; REVIEW; RHINOSINUSITIS; SIDE EFFECT; STOMACH IRRITATION; TREATMENT OUTCOME;

ASPIRIN; CHRONIC DISEASE; DESENSITIZATION, IMMUNOLOGIC; DRUG HYPERSENSITIVITY; HUMANS; NASAL POLYPS; RESPIRATORY HYPERSENSITIVITY; RHINITIS; SINUSITIS;

EID: 79958059857     PISSN: 10689508     EISSN: 15316998     Source Type: Journal    
DOI: 10.1097/MOO.0b013e3283450102     Document Type: Review

References (45)

1. Ferguson BJ, Otto B, Pant H. When surgery, antibiotics and steroids fail to resolve chronic rhinosinusitis. Immunol Allergy Clin North Am 2009; 29:719-732.
2. Simon R. Adverse respiratory reactions to aspirin and nonsteroidal antiinflammatory drugs. Curr Allergy Asthma Rep 2004; 4:17-24. (Pubitemid 38899114)
3. Pfaar O, Klimek L. Aspirin desensitization in aspirin intolerance: update on current standards and recent improvements. Curr Opin Allergy Clin Immunol 2006; 6:161-166. (Pubitemid 44510196)
4. Ortega-Loayza AG, Raza S, Minisi AJ, et al. Aspirin desensitization/ challenge in 3 patients with unstable angina. Am J Med Sci 2010; 340:418-420.
5. Stevenson D. Aspirin sensitivity and desensitization for asthma and sinusitis. Curr Allergy Asthma Rep 2009; 9:155-163.
6. Fokkens WJ, Lund VJ, Mullol J, et al. European Position Paper on Nasal Polyps 2007. Rhinology; 45 (Suppl 20):1-139.
7. Szczeklik A, Stevenson D. Aspirin-induced asthma: advances in pathogenesis, diagnosis and management. J Allergy Clin Immunol 2003; 11:913-921. (Pubitemid 36570845)
8. Szczeklik A, Sanak M, Nizankowska-Mogilnicka E, Kiełbasa B. Aspirin intolerance and the cyclooxygenase-leukotriene pathways. Curr Opin Pulm Med 2004; 10:51-56.
9. Ferguson BJ. Categorization of eosinophilic chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg 2004; 12:237-242. (Pubitemid 38679965)
10. Cook PR. The role of aspirin sensitivity and nasal polyposis. Curr Opin Otolaryngol Head Neck Surg 2002; 10:213-216. (Pubitemid 34553621)
11. Morwood K, Gillis D, Smith W, Kette F. Aspirin-sensitive asthma. Int Med J 2005; 35:240-246. (Pubitemid 40529586)
12. Ying S, Meng Q, Scadding G, et al. Aspirin-sensitive rhinosinusitis is associated with reduced E-prostanoid 2 receptor expression on nasal mucosal inflammatory cells. J Allergy Clin Immunol 2006; 117:312-318. (Pubitemid 43190145)
13. Sousa A, Parikh A, Scadding G, et al. Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. N Engl J Med 2002; 347:1493-1499. (Pubitemid 35257588)
14. Kim SH, Ye YM, Hur GY, et al. CysLTR1 promoter polymorphism and requirement for leukotriene receptor antagonist in aspirin-intolerant asthma patients. Pharmacogenomics 2007; 8:1143-1150. (Pubitemid 47578223)
15. Kim SH, Yang ME, Lee HN, et al. Combined effect of IL-10 and TGF-b1 promoter polymorphisms as a risk factor for aspirin-intolerant asthma and rhinosinusitis. Allergy 2009; 64:1221-1225.
16. Klimek L, Pfaar O. Aspirin intolerance: does desensitization alter the course of the disease? Immunol Allergy Clin North Am 2009; 29:669-675.
17. Szczeklik A. Aspirin-induced asthma: a tribute to John Vane as a source of inspiration. Pharmacol Rep 2010; 62:526-529.
18. Palikhe NS, Kim JH, Park HS. Update on recent advances in the management of aspirin exacerbated respiratory disease. Yonsei Med J 2009; 50:744-750.
19. Williams A, Simon R, Woessner K, Stevenson D. The relationship between historical aspirin-induced asthma and severity of asthma induced during oral aspirin challenges. J Allergy Clin Immunol 2007; 120:273-277. (Pubitemid 47102372)
20. Hope A, Woessner K, Simon R, Stevenson D. Rational approach to aspirin dosing during oral challenges and desensitization of patients with aspirinexacerbated respiratory disease. J Allergy Clin Immunol 2009; 123:406-410.
21. Stevenson DD, Simon RA, Mathison DA. Aspirin-sensitive asthma: tolerance to aspirin after positive oral aspirin challenges. J Allergy Clin Immunol 1980; 66:82-88. (Pubitemid 10056834)
22. Sweet JM, Stevenson DD, Simon RA, Mathison DA. Long term effects of aspirin desensitization treatment for aspirin-sensitive rhinosinusitis asthma. J Allergy Clin Immunol 1990; 85 (1 Pt 1):59-65. (Pubitemid 20058882)
23. Castells M. Rapid desensitization for hypersensitivity reactions to medications. Immunol Allergy Clin North Am 2009; 29:585-606.
24. Simon R. Prevention and treatment of reactions to NSAIDs. Clin Rev Allergy Immunol 2003; 24:189-197. (Pubitemid 36438922)
25. McCains KC, Kountakis S. Medical and surgical considerations in patients with Samter's triad. Am J Rhinol 2006; 20:573-576. (Pubitemid 44963816)
26. Berges-Simeno MP, Simon R, Stevenson D. Long term treatment with aspirin desensitization in asthmatic patients with aspirin exacerbated respiratory disease. J Allergy Clin Immunol 2003; 111:180-186. (Pubitemid 36143311)
27. Szczeklik A, Nizankowska E, Duplaga M. Natural history of aspirin-induced asthma. Eur Respir J 2000; 16:432-436.
28. Lee J, Simon R, Stevenson D. Selection of aspirin dosages for aspirin desensitization treatment in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol 2007; 119:157-164. (Pubitemid 46037806)
29. Berges-Gimeno MP, Simon RA, Stevenson DD. Early effects of aspirin desensitization treatment in asthmatic patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 2003; 90:338-341. (Pubitemid 36363092)
30. Lee R, White A, Ding D, et al. Use of intranasal ketorolac and modified oral aspirin challenge for desensitization of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 2010; 105:130-135.
31. Kowalski M. Management of aspirin-sensitive rhinosinusitis-asthma syndrome: what role for aspirin desensitization? Allergy Proc 1992; 13:175-183.
32. Stevenson D, Simon R. Selection of patients for aspirin desensitization treatment. J Allergy Clin Immunol 2006; 118:801-804. (Pubitemid 44498748)
33. White A, Stevenson D. Does suppression of Il-4 synthesis by aspirin explain the therapeutic benefit of aspirin desensitization treatment? J Allergy Clin Immunol 2010; 126:745-746.
34. Gosepath J, Pogodsky T, Mann WJ. Characteristics of recurrent chronic rhinosinusitis after previous surgical therapy. Acta Otolaryngol 2008; 128: 778-784. (Pubitemid 351882529)
35. Gosepath J, Schaefer D, Amedee R, Mann WJ. Individual monitoring of aspirin desensitization. Arch Otolaryngol Head Neck Surg 2001; 127:316-321. (Pubitemid 32205391)
36. DeMarcantonio M, Han J. Systemic therapies in managing sinonasal inflammation. Otolaryngol Clin North Am 2010; 43:551-563.
37. Rozsasi A, Polzehl D, Deutschle T, et al. Long term treatment with aspirin desensitization: a prospective clinical trial comparing 100 and 300mg aspirin daily. Allergy 2008; 63:1228-1234.
38. Patriarca G, Schiavino D, Nucera E, et al. Prevention of relapse in nasal polyposis. Lancet 1991; 337:1488.
39. Parikh A, Scadding G. Intranasal lysine-aspirin in aspirin-sensitive nasal polyposis: a controlled trial. Laryngoscope 2005; 115:1385-1390. (Pubitemid 41105844)
40. Pfaar O, Klimek L. Eicosanoids, aspirin-intolerance and the upper airways: current standards and recent improvements of the desensitization therapy. J Phys Pharmacol 2006; 57 (Suppl 12):5-13. (Pubitemid 46569824)
41. Szczeklik A, Nizankowska E, Sanak M, Swierczynska M. Aspirin-induced rhinitis and asthma. Curr Opin Allergy Clin Immunol 2001; 1:27-33.
42. Steinke JW, Culp J, Kropf E, Borish L. Modulation by aspirin of nuclear phospho-signal transducer and activator of transcription 6 expression: possible role in therapeutic benefit associated with aspirin desensitization. J Allergy Clin Immunol 2009; 124:724-730.
43. Katial R, Strand M, Prasertsuntarasai T, et al. The effect of aspirin desensitization on novel biomarkers in aspirin-exacerbated respiratory diseases. J Allergy Clin Immunol 2010; 126:738-744.
44. Williams A, Woessner K. The clinical effectiveness of aspirin desensitization in chronic rhinosinusitis. Curr Allergy Asthma Rep 2008; 8:245-252.
45. Lee J, Simon R. Does it make sense to 'desens'? Aspirin desensitization in the treatment of chronic rhinosinusitis. Curr Allergy Asthma Rep 2006; 6:183-184. (Pubitemid 43970984)